No link between COVID-19 vaccination in pregnancy and higher risk of preterm birth or stillbirth

Australia News News

No link between COVID-19 vaccination in pregnancy and higher risk of preterm birth or stillbirth
Australia Latest News,Australia Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

No link between COVID-19 vaccination in pregnancy and higher risk of pretermbirth or stillbirth bmj_latest

Vaccination against COVID-19 during pregnancy is not associated with a higher risk of preterm birth, small for gestational age at birth, or stillbirth, concludes a large study from Canada published byThese findings can help inform evidence based decision making about the risks and benefits of COVID-19 vaccination duringCOVID-19 infection during pregnancy has been associated with higher risks of complications, including admission to hospital and death for pregnant individuals, as well asCOVID-19...

A wide range of potentially influential factors were taken into account. These included mother's age at delivery, pre-pregnancy body mass index, reported smoking or However, results remained unchanged in additional sensitivity analyses designed to assess the impact of different methodological approaches, suggesting that they are likely to be robust.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study - BMC Infectious DiseasesCould widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study - BMC Infectious DiseasesBackground Despite the development of safe and effective vaccines, effective treatments for COVID-19 disease are still urgently needed. Several antiviral drugs have shown to be effective in reducing progression of COVID-19 disease. Methods In the present work, we use an agent-based mathematical model to assess the potential population impact of the use of antiviral treatments in four countries with different demographic structure and current levels of vaccination coverage: Kenya, Mexico, United States (US) and Belgium. We analyzed antiviral effects on reducing hospitalization and death, and potential antiviral effects on reducing transmission. For each country, we varied daily treatment initiation rate (DTIR) and antiviral effect in reducing transmission (AVT). Results Irrespective of location and AVT, widespread antiviral treatment of symptomatic adult infections (20% DTIR) prevented the majority of COVID-19 deaths, and recruiting 6% of all adult symptomatic infections daily reduced mortality by over 20% in all countries. Furthermore, our model projected that targeting antiviral treatment to the oldest age group (65 years old and older, DTIR of 20%) can prevent over 30% of deaths. Our results suggest that early antiviral treatment (as soon as possible after inception of infection) is needed to mitigate transmission, preventing 50% more infections compared to late treatment (started 3 to 5 days after symptoms onset). Our results highlight the synergistic effect of vaccination and antiviral treatment: as the vaccination rate increases, antivirals have a larger relative impact on population transmission. Finally, our model projects that even in highly vaccinated populations, adding antiviral treatment can be extremely helpful to mitigate COVID-19 deaths. Conclusions These results suggest that antiviral treatments can become a strategic tool that, in combination with vaccination, can significantly reduce COVID-19 hospitalizations and deaths and can help control SARS-Co
Read more »

Increased risk of some neurological and psychiatric disorders remains two years after COVID-19 infectionIncreased risk of some neurological and psychiatric disorders remains two years after COVID-19 infectionA new study published in The Lancet Psychiatry from the University of Oxford and the National Institute for Health and Care Research (NIHR) Oxford Health Biomedical Research Centre investigated neurological and psychiatric diagnoses in over 1.25 million people following diagnosed COVID-19 infection, using data from the US-based TriNetX electronic health record network.
Read more »

Jill Biden Tests Positive for COVID-19, Has ‘Mild' SymptomsJill Biden Tests Positive for COVID-19, Has ‘Mild' SymptomsFirst lady Jill Biden tested positive for COVID-19 and was experiencing “mild symptoms,” the White House announced Tuesday. President Joe Biden continues to test negative after recently recovering from the virus but will wear a mask indoors for 10 days as a precaution. The Bidens have been vacationing in South Carolina since Aug. 10, and the 71-year-old first lady began experiencing symptoms…
Read more »

US first lady Jill Biden tests positive for COVID-19US first lady Jill Biden tests positive for COVID-19US First Lady Jill Biden has tested positive for COVID-19, the White House has said.
Read more »

YouTuber misinterprets Covid-19 vaccine evidence on children from Singapore - Full FactYouTuber misinterprets Covid-19 vaccine evidence on children from Singapore - Full FactDr John Campbell claims that new evidence shows more children “suffered a severe reaction to vaccine” than required oxygen therapy for Covid-19. But this is incorrect, and the comparison is flawed.
Read more »

Bradford hospital: Operating theatre plan a 'matter of priority'Bradford hospital: Operating theatre plan a 'matter of priority'The Covid-19 pandemic has highlighted the need for additional operating theatres, an NHS trust says.
Read more »



Render Time: 2025-03-09 08:49:20